drugset / Trial / NCT03731364

Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty

NCT03731364

Phase 2 Completed 55 enrolled Concentric Analgesics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a two-part, Phase 2, multi-center, randomized, double-blind, placebo-controlled, parallel design study of CA-008 (vocacapsaicin) vs. placebo injected/instilled during an elective TKA.

Timeline

Start
2018-10-29
Primary completion
2019-04-30
Completion
2019-05-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator vocacapsaicin Small molecule 5 mg Other
Comparator vocacapsaicin Small molecule 10 mg Other
Comparator vocacapsaicin Small molecule 15 mg Other

Indications

No indication recorded.